1. Takahashi, Mariko, Lio, Chan-Wang J, Campeau, Anaamika, Jain, Mohit, Sharma, Sonia. 2021. The tumor suppressor kinase DAPK3 drives tumor-intrinsic immunity through the STING-IFN-β pathway. In Nature immunology, 22, 485-496. doi:10.1038/s41590-021-00896-3. https://pubmed.ncbi.nlm.nih.gov/33767426/
2. Li, Guan-Man, Li, Lei, Li, Meng-Qing, Guan, Xin-Yuan, Bi, Jiong. 2020. DAPK3 inhibits gastric cancer progression via activation of ULK1-dependent autophagy. In Cell death and differentiation, 28, 952-967. doi:10.1038/s41418-020-00627-5. https://pubmed.ncbi.nlm.nih.gov/33037394/
3. Kocher, Brandon A, White, Lynn S, Piwnica-Worms, David. 2014. DAPK3 suppresses acini morphogenesis and is required for mouse development. In Molecular cancer research : MCR, 13, 358-67. doi:10.1158/1541-7786.MCR-14-0333. https://pubmed.ncbi.nlm.nih.gov/25304685/
4. Wang, Yanling, Ji, Lulu, Peng, Zhihong, Hu, Hanyang, Wang, Lin. 2019. Silencing DAPK3 blocks the autophagosome-lysosome fusion by mediating SNAP29 in trophoblast cells under high glucose treatment. In Molecular and cellular endocrinology, 502, 110674. doi:10.1016/j.mce.2019.110674. https://pubmed.ncbi.nlm.nih.gov/31811899/
5. Mudry, Jonathan M, Lassiter, David G, Nylén, Carolina, Krook, Anna, Zierath, Juleen R. 2016. Insulin and Glucose Alter Death-Associated Protein Kinase 3 (DAPK3) DNA Methylation in Human Skeletal Muscle. In Diabetes, 66, 651-662. doi:10.2337/db16-0882. https://pubmed.ncbi.nlm.nih.gov/28011458/
6. Park, Ji-Eun, Park, Jeong Woo, Sim, Myong-Kyu, Kim, So Ra, Kim, Kwang Seok. . Inhibition of DAPK3 Suppresses Radiation-Induced Cellular Senescence by Activation of a PGC1α-Dependent Metabolism Pathway in Brain Endothelial Cells. In The journals of gerontology. Series A, Biological sciences and medical sciences, 79, . doi:10.1093/gerona/glae088. https://pubmed.ncbi.nlm.nih.gov/38563090/
7. Kake, Satoru, Usui, Tatsuya, Ohama, Takashi, Yamawaki, Hideyuki, Sato, Koichi. 2017. Death-associated protein kinase 3 controls the tumor progression of A549 cells through ERK MAPK/c-Myc signaling. In Oncology reports, 37, 1100-1106. doi:10.3892/or.2017.5359. https://pubmed.ncbi.nlm.nih.gov/28075459/
8. Liu, Wentao, Zhang, Bin, Zhang, Dan, Zhu, Liang, Jin, Xin. 2022. The RBPJ/DAPK3/UBE3A signaling axis induces PBRM1 degradation to modulate the sensitivity of renal cell carcinoma to CDK4/6 inhibitors. In Cell death & disease, 13, 295. doi:10.1038/s41419-022-04760-6. https://pubmed.ncbi.nlm.nih.gov/35368029/
智鼠故事 
